InfusionCapital President & CEO, Kelly McCarthy,
Completes Prestigious Harvard Business School Program
ORLANDO,
Florida – July 20, 2005 – InfusionCapital, a
leading small cap investment banking advisory firm,
announced today that Kelly McCarthy, its President and
CEO, completed Harvard Business School’s continuing
education program, Making Corporate Boards More
Effective. The prestigious program is offered only
twice annually and is attended by approximately forty
CEOs and directors from Fortune 500 companies.
Corporate boards face
greater challenges today than ever before. These
challenges include enabling a group of independent
directors to understand their company's business so that
they can approve the company's strategy, monitor its
performance, evaluate and compensate their CEO, enhance
the development of the next generation of top
management, and ensure compliance with laws,
regulations, and ethical standards.
The Harvard
Business School continuing education program
provides directors,
including board leaders of public companies, with an
enlightened perspective on their expanding roles. This
includes how to improve the functioning of their boards
so as to achieve the boards' goals in this challenging
new era of corporate governance.
“In keeping with
InfusionCapital’s objective of providing our clients
with the absolute best counsel on corporate governance,”
stated Kelly McCarthy, “it was an honor to be accepted
into the Harvard Business School continuing education
program.”
A link to Harvard Business
School Executive Education Program can be found here:
http://www.exed.hbs.edu/programs/mcb/
About
InfusionCapital:
InfusionCapital (www.InfusionCapital.com),
an investment banking consultancy firm, specializes in a
unique, integrated approach to capital formation for
small cap and emerging growth companies. The firm has
extensive experience in assisting client companies with
each phase of capitalization and the complex processes
that accompany it.
InfusionCapital cares about our community and about the
needs of others. Throughout the year, our firm
contributes to organizations and groups, including
investment of volunteer hours by executives and staff,
who serve on boards and committees for numerous
charities, foundations and charitable events.
For more
information, contact:
Andrew Zelman
InfusionCapital
407-566-1090
www.InfusionCapital.com
